ELRANATAMAB

Clinical trials for ELRANATAMAB explained in plain language.

Never miss a new study

Get alerted when new ELRANATAMAB trials appear

Sign up with your email to follow new studies for ELRANATAMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Radiation 'Priming' tested to supercharge cancer drug

Disease control Not yet recruiting

This study is testing whether giving low doses of radiation therapy before a new drug called elranatamab can help the drug work better against a hard-to-treat form of multiple myeloma. It will involve about 34 adults whose cancer has returned or stopped responding to standard tre…

Matched conditions: ELRANATAMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 12, 2026 13:50 UTC

ELRANATAMAB

Get alerted when new ELRANATAMAB trials appear

Radiation 'Priming' tested to supercharge cancer drug